Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
Published on: July 19, 2024
Tracheobronchial amyloidosis managed with multimodality therapies
Philip Sommer1, Gagan Kumar, Randolph J Lipchik
1Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Tracheobronchial amyloidosis, a rare systemic disease manifestation, can cause organ dysfunction. Two cases were successfully treated using a combination of surgery and radiation therapy.
Area of Science:
- Pulmonary Medicine
- Pathology
Background:
- Amyloidosis is a systemic disease characterized by abnormal extracellular deposition of amyloid fibrils.
- These protein deposits, primarily in beta-pleated sheets, can lead to organ dysfunction.
Observation:
- Respiratory tract involvement in amyloidosis is uncommon.
- Two distinct cases of tracheobronchial amyloidosis were identified.
Findings:
- Both cases of tracheobronchial amyloidosis demonstrated successful treatment outcomes.
- A combined therapeutic approach involving surgery and radiation was employed.
Implications:
- Surgical and radiation interventions offer a viable treatment strategy for tracheobronchial amyloidosis.
- Highlights the potential for managing rare manifestations of systemic amyloidosis.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Asthma-IV: Nursing Management
First, in...

